Organon & Co | OGN - فروش و مدیریت هزینه

قیمت سهام
6.27
تغییر روزانه
-0.08 -1.26%
ماهیانه
-13.87%
سالیانه
-59.86%
Q1 پیش بینی
6.16




فروش و مدیریت هزینه تغییر دادن تاریخ
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Celltrion KRW 249.98B 16.36B 2025-09
Cspc Pharmaceutical CNY 1.97B 404.66M 2025-09
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 8.2M 669K 2025-09
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Gilead Sciences USD 1.78B 425M 2025-12
Glaxosmithkline GBP 2.91B 817.89M 2025-09
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Merck USD 2.85B 215M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Novartis USD 3.3B 137M 2025-09
Organigram Holdings CAD 8.86M 499K 2025-09
Organon & Co USD 399M 54M 2025-09
Ovoca Bio EUR 2.96M 8K 2022-06
Pharma Mar EUR 17.31M 3.6M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Sartorius EUR 218.7M 6.5M 2025-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tilray USD 24.85M 1.7M 2025-09